Bionovate Technologies Corp. (BIIO) financial statements (2022 and earlier)

Company profile

Business Address GEWERBESTRASSE 10
CHAM, 6330
State of Incorp. NV
Fiscal Year End June 30
SIC 364 - Electric Lighting And Wiring Equipment (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

9/30/2021
TTM
6/30/2021
6/30/2020
6/30/2019
6/30/2018
6/30/2017
6/30/2016
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments      1
Cash and cash equivalents      1
Total current assets:      1
Noncurrent Assets
Intangible assets, net (including goodwill)    20  
Intangible assets, net (excluding goodwill)    20  
Total noncurrent assets:    20  
TOTAL ASSETS:    20 1
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including: 266211108413921
Accounts payable 3226   21
Accrued liabilities  132 24  
Other undisclosed accounts payable and accrued liabilities 234541081739 
Debt 185 418343 
Due to related parties 52 41186147130
Other undisclosed current liabilities  185143   
Total current liabilities: 503397332310229152
Noncurrent Liabilities
Total liabilities: 503397332310229152
Stockholders' equity
Stockholders' equity attributable to parent (503)(397)(332)(310)(229)(151)
Common stock 162202
Additional paid in capital 2,3012,2962,2422,056383112
Accumulated other comprehensive income     1416
Accumulated deficit (2,805)(2,698)(2,576)(2,367)(627)(280)
Total stockholders' equity: (503)(397)(332)(310)(229)(151)
TOTAL LIABILITIES AND EQUITY:      1

Income statement (P&L) ($ in thousands)

9/30/2021
TTM
6/30/2021
6/30/2020
6/30/2019
6/30/2018
6/30/2017
6/30/2016
Revenues     56
Cost of revenue
(Cost of Goods and Services Sold)
     (4)(5)
Gross profit:     11
Operating expenses (45)(33)(57)(119)(89)(39)
Operating loss: (45)(33)(57)(119)(88)(38)
Nonoperating expense (61)(89)(152)(1,622)(253) 
Debt instrument, convertible, beneficial conversion feature   101   
Other nonoperating expense (61)(89)    
Interest and debt expense (61)(62)(51)(16)(61) 
Loss from continuing operations before income taxes: (167)(184)(260)(1,757)(402)(38)
Other undisclosed income from continuing operations 6162511661 
Loss from continuing operations: (107)(122)(209)(1,741)(341)(38)
Income from discontinued operations     17 
Net loss: (107)(122)(209)(1,741)(324)(38)
Net income attributable to noncontrolling interest     1 
Other undisclosed net loss attributable to parent     (1) 
Net loss attributable to parent: (107)(122)(209)(1,741)(324)(38)
Other undisclosed net income available to common stockholders, basic     1 
Net loss available to common stockholders, diluted: (107)(122)(209)(1,741)(323)(38)

Comprehensive Income ($ in thousands)

9/30/2021
TTM
6/30/2021
6/30/2020
6/30/2019
6/30/2018
6/30/2017
6/30/2016
Net loss: (107)(122)(209)(1,741)(324)(38)
Other comprehensive income (loss) (45)(40)(45)(65)(30)4
Comprehensive loss: (151)(162)(254)(1,806)(354)(34)
Comprehensive income, net of tax, attributable to noncontrolling interest     1 
Other undisclosed comprehensive income, net of tax, attributable to parent   455128 
Comprehensive loss, net of tax, attributable to parent: (151)(162)(209)(1,755)(325)(34)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: